Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright Healthcare Technical Leaders Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least ... The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright Healthcare Technical Leaders Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or momentum characteristics. Mehr anzeigen
NEW YORK, Oct. 12 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today announced that it has launched trading in 11 new exchange traded funds (ETFs) from PowerShares Capital Management...
RNS Number:6652U PPL Therapeutics PLC 27 January 2004 Date: Immediate, Tuesday 27 January 2004 Contact: Chris Greig, Chairman Lindsay Dunsmuir, Chief Financial Officer PPL Therapeutics...
RNS Number:2576U PPL Therapeutics PLC 15 January 2004 Date: Embargoed until 07.00 am, Thursday 15 January 2004 Contact: Chris Greig, Chairman Lindsay Dunsmuir, Chief Financial Officer...
RNS Number:9336T Sharp (James) & Co 7 January 2004 Date of Disclosure 7TH JANUARY 2004 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date...
RNS Number:8889T Sharp (James) & Co 6 January 2004 Date of Disclosure 6TH JANUARY 2004 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS...
RNS Number:7521T PPL Therapeutics PLC 31 December 2003 PPL Therapeutics plc For immediate release 31 December 2003 PPL Therapeutics plc ("PPL") Disposal of the NT intellectual...
RNS Number:6005T PPL Therapeutics PLC 23 December 2003 Date: Immediate release, Tuesday 23 December 2003 Contact: Chris Greig, Chairman Lindsay Dunsmuir, Chief Financial Officer PPL...
RNS Number:0709T PPL Therapeutics PLC 10 December 2003 Date: Embargoed until 07.00 am, Wednesday 10 December 2003 Contact: Chris Greig, Chairman Lindsay Dunsmuir...
RNS Number:8211S Innovation Development Limited 3 December 2003 Date of Disclosure 3RD DECEMBER 2003 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND...
RNS Number:8008S Innovation Development Limited 3 December 2003 Date of Disclosure 3RD DECEMBER 2003 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.95 | -2.09713024283 | 45.3 | 45.462 | 44.2 | 5220 | 44.90123575 | SP |
| 4 | -2.19 | -4.70562956596 | 46.54 | 48.63 | 43.48 | 9163 | 45.63526168 | SP |
| 12 | -0.31 | -0.694133452754 | 44.66 | 48.63 | 43.48 | 7959 | 45.97022366 | SP |
| 26 | 2.11 | 4.99526515152 | 42.24 | 48.63 | 40.69 | 9896 | 45.15027277 | SP |
| 52 | 10.23 | 29.9824150059 | 34.12 | 48.63 | 34.08 | 14409 | 42.46588751 | SP |
| 156 | -3.5941491 | -7.4965332944 | 47.9441491 | 52.0924892 | 29.08 | 11907 | 40.92064548 | SP |
| 260 | 14.41864331 | 48.1723680598 | 29.93135669 | 64.62927277 | 23.12741253 | 23493 | 44.00446747 | SP |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
